← Open Payments lookup

ELIZABETH PRINCE-COLEMAN: Open Payments

NPI 1316378748 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$536 in 24 payments from 11 companies in 2025. Trend: 2023 $530 · 2024 $200 · 2025 $536

Food & beverage: $536
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$85
Amneal Pharmaceuticals LLC3$76
Averitas Pharma Inc.3$74
ACADIA Pharmaceuticals Inc3$61
Merz Pharmaceuticals, LLC3$58
Biogen, Inc.2$53
UCB, Inc.2$51
Teva Pharmaceuticals USA, Inc.1$24
Alexion Pharmaceuticals, Inc.1$19
Ipsen Biopharmaceuticals, Inc1$19

Products named: INGREZZA, CREXONT, QUTENZA, NUPLAZID, INBRIJA, SKYCLARYS, Zilbrysq, AUSTEDO XR.

Industry payments across GA — which companies pay providers there.